Gregory Rowin, DO
Plastic Surgery within the Head & Neck · McAllen, TXNPI 1821093212
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $3,233 of the $4,061 with a category attached, or 79.6%. 12 manufacturers reported payments, led by Stryker at 39.2% of the total. Reporting peaked in 2023 at $1,272 and has fallen 77.6% since, to $285 in 2024.
Across 132 payments — averaging $30.76 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Stryker$2K
- Medtronic$1K
- Optinose US, Inc.$646
- Regeneron Healthcare Solutions, Inc.$264
- GSK$70
- Phadia US Inc.$47
- plus $106 from 6 others
What the payments were for
- Travel & lodging$82820%
- Food & beverage$3,23380%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Stryker | 65 | $1,591 |
| Medtronic | 15 | $1,337 |
| Optinose US, Inc. | 27 | $646 |
| Regeneron Healthcare Solutions, Inc. | 12 | $264 |
| GSK | 4 | $70 |
| Phadia US Inc. | 3 | $47 |
| Novartis | 1 | $22 |
| Acclarent, Inc | 1 | $21 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $20 |
| Tactile Systems Technology Inc | 1 | $15 |
| Olympus America Inc. | 1 | $15 |
| Inspire Medical Systems, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- FUSION$775
- ENTELLUS - XPRESS ENT DILATION SYSTEM$294
- Xhance$236
- SPIROX - LATERA$233
- PROPEL$125
How this compares
$4,061 in reported general payments places this provider in the 75th percentile of 50 plastic surgery within the head & neck providers in Texas.
See all plastic surgery within the head & neck providers in Texas →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Fluticasone Propionate | 280 | $4,679 |
| Azelastine Hcl | 163 | $4,676 |
| Ipratropium Bromide | 138 | $4,485 |
| Ofloxacin | 33 | $892 |
| Cephalexin | 54 | $478 |
| Clotrimazole | 16 | $406 |
| Methylprednisolone | 24 | $198 |
| Pantoprazole Sodium | 19 | $185 |
| Montelukast Sodium | 23 | $114 |
| Acetaminophen-CodeineAcetaminophen With Codeine | 17 | $85 |
| Levocetirizine Dihydrochloride | 11 | $61 |
| Omeprazole | 12 | $55 |
Paid to pharmacies, not to this prescriber.
Other plastic surgery within the head & neck in McAllen
- Frank GlatzMcAllen$23K
- John AustinMcAllen$2K
- Joseph HemerMcAllen$1K
- Simon MilovMcAllen$290
- Sean BoutrosHouston$335K
- Baran SumerDallas$91K
- Anthony BrissettHouston$25K
- Jack HuaRichmond$25K
- Sarah FrommerAustin$7K
- Wilbur HahOrange$7K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.